What Clinicians Should Know About the QT Interval
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
CONTEXT: Of the several factors implicated in causing QT interval prolongation and torsades de pointes, errors in the use of medications that may prolong this interval deserve special attention. OBJECTIVE: To systematically summarize the available clinical data on the QT interval and to offer improved recommendations for the use of QT-prolonging medications. DATA SOURCES: We searched MEDLINE from 1966 through 2002 for all English-language articles related to the QT interval. Additional data sources included bibliographies of articles identified on MEDLINE, a survey of experts, and data presented at a meeting of experts on long QT syndrome. STUDY SELECTION: We selected for review registries and case series examining clinical outcomes of patients with prolonged QT interval and the effect of different methods of measurement of the QT interval on patient outcomes. Ten studies were identified, of which 6 were included in the analysis. DATA EXTRACTION: Data quality was determined by publication in the peer-reviewed literature. DATA SYNTHESIS: Optimal measurement of the QT interval is problematic because of lack of standardization and lack of data regarding the best way to adjust for heart rate. Reliable information on the proper use of QT-prolonging medications is scarce. Although a QT interval of at least 500 milliseconds generally has been shown to correlate with a higher risk of torsades de pointes, there is no established threshold below which prolongation of the QT interval is considered free of proarrhythmic risk. The risk of torsades de pointes should be assessed in patients who are about to begin taking a QT-prolonging medication. Although inadequate clinical studies preclude prediction of absolute risk for individual patients, particularly high-risk situations can be defined based on clinical variables. We propose recommendations on proper monitoring of the QT interval in patients receiving QT-prolonging medications. CONCLUSION: Although the use of QT-prolonging medications can predispose to torsades de pointes, there is a relative paucity of information that can help clinicians and patients make optimal informed decisions about how best to minimize the risk of this serious complication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schwartz, P. J., Priori, S. G., Spazzolini, C., Moss, A. J., Vincent, G. M., Napolitano, C., Denjoy, I., Guicheney, P., Breithardt, G., Keating, M. T., et al. (2001) · Circulation · doi:10.1161/01.cir.103.1.89 · Cited by 1,779
Waldo, A. L., Camm, A. J., deRuyter, H., Friedman, P. L., MacNeil, D. J., Pauls, J. F., Pitt, B., Pratt, C. M., Schwartz, P. J., & Veltri, E. P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)02149-6 · Cited by 1,371
Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction
Torp-Pedersen, C., Møller, M., Bloch-Thomsen, P. E., Køber, L., Sandøe, E., Egstrup, K., Agner, E., Carlsen, J., Videbæk, J., Marchant, B., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411201 · Cited by 1,012
Female Gender as a Risk Factor for Torsades de Pointes Associated With Cardiovascular Drugs
Makkar, R. R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510210076031 · Cited by 971
The long QT syndrome. Prospective longitudinal study of 328 families.
Moss, A. J., Schwartz, P. J., Crampton, R. S., Tzivoni, D., Locati, E. H., MacCluer, J., Hall, W. J., Weitkamp, L., Vincent, G. M., & Garson, A. (1991) · Circulation · doi:10.1161/01.cir.84.3.1136 · Cited by 968
Coplen, S. E., Antman, E. M., Berlin, J. A., Hewitt, P., & Chalmers, T. C. (1990) · Circulation · doi:10.1161/01.cir.82.4.1106 · Cited by 945
Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden Death
Glassman, A. H., & Bigger, J. T. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1774 · Cited by 822
Schwartz, P. J., Priori, S. G., Locati, E. H., Napolitano, C., Cantù, F., Towbin, J. A., Keating, M. T., Hammoude, H., Brown, A. M., Chen, L.-S. K., et al. (1995) · Circulation · doi:10.1161/01.cir.92.12.3381 · Cited by 816
Low Penetrance in the Long-QT Syndrome: Clinical Impact
Priori, S. G., Napolitano, C., & Schwartz, P. J. (1999) · Circulation · doi:10.1161/01.cir.99.4.529 · Cited by 804
Influence of the Genotype on the Clinical Course of the Long-QT Syndrome
Zareba, W., Moss, A. J., Schwartz, P. J., Vincent, G. M., Robinson, J. L., Priori, S. G., Benhorin, J., Locati, E. H., Towbin, J. A., Keating, M. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810013391404 · Cited by 754
Long QT syndromes and torsade de pointes
Viskin, S. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02107-8 · Cited by 689
ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome
Moss, A. J., Zareba, W., Benhorin, J., Locati, E. H., Hall, W. J., Robinson, J. L., Schwartz, P. J., Towbin, J. A., Vincent, G. M., Lehmann, M. H., et al. (1995) · Circulation · doi:10.1161/01.cir.92.10.2929 · Cited by 616
QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients
Reilly, J., Ayis, S., Ferrier, I., Jones, S., & Thomas, S. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02035-3 · Cited by 602 · cited 1×
“Some antipsychotic drugs have been shown to prolong the QT interval.(51,52)”
BackgroundLocati, E. H., Zareba, W., Moss, A. J., Schwartz, P. J., Vincent, G. M., Lehmann, M. H., Towbin, J. A., Priori, S. G., Napolitano, C., Robinson, J. L., et al. (1998) · Circulation · doi:10.1161/01.cir.97.22.2237 · Cited by 493
Zhang, L., Timothy, K. W., Vincent, G. M., Lehmann, M. H., Fox, J., Giuli, L. C., Shen, J., Splawski, I., Priori, S. G., Compton, S. J., et al. (2000) · Circulation · doi:10.1161/01.cir.102.23.2849 · Cited by 470
Neal Kay, G., Vance J., P., Joaquin G., A., Richard W., H., & Albert L., W. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80226-5 · Cited by 463
Antipsychotics and the Risk of Sudden Cardiac Death
Ray, W. A., Meredith, S., Thapa, P. B., Meador, K. G., Hall, K., & Murray, K. T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.12.1161 · Cited by 429
Prevention of Implantable-Defibrillator Shocks by Treatment with Sotalol
Pacifico, A., Hohnloser, S. H., Williams, J. H., Tao, B., Saksena, S., Henry, P. D., & Prystowsky, E. N. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402402 · Cited by 422 · cited 1×
“When antiarrhythmic therapy is used for patients with symptoms of chronic arrhythmias, the risk may outweigh the benefit because few studies have shown a significant effect of antiarrhythmic therapy in this situation.(43) The risks are particularly disconcerting with antiarrhythmic medications that have been shown to…”
MethodRate-corrected QT interval: Techniques and limitations
Funck-Brentano, C., & Jaillon, P. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90035-b · Cited by 401
Moss, A. J., Zareba, W., Kaufman, E. S., Gartman, E., Peterson, D. R., Benhorin, J., Towbin, J. A., Keating, M. T., Priori, S. G., Schwartz, P. J., et al. (2002) · Circulation · doi:10.1161/hc0702.105124 · Cited by 397
KVLQT1 C-Terminal Missense Mutation Causes a Forme Fruste Long-QT Syndrome
Donger, C., Denjoy, I., Berthet, M., Neyroud, N., Cruaud, C., Bennaceur, M., Chivoret, G., Schwartz, K., Coumel, P., & Guicheney, P. (1997) · Circulation · doi:10.1161/01.cir.96.9.2778 · Cited by 348
The long QT syndromes: genetic basis and clinical implications
Chiang, C.-E., & Roden, D. M. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00716-6 · Cited by 328
Diurnal pattern of QTc interval: How long is prolonged?
Molnar, J., Zhang, F., Weiss, J., Ehlert, F. A., & Rosenthal, J. E. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00426-2 · Cited by 312 · cited 2×
“Interobserver variability also results from the lack of agreement among experts about standardizing approaches to measure the QT interval.(11,12) Although experts on the QT interval argue that intraobserver and interobserver variability and measurement error are higher when the corrected QT (QTc) interval is taken fro…”
BackgroundWilde, A. A. M., Jongbloed, R. J. E., Doevendans, P. A., Düren, D. R., Hauer, R. N. W., van Langen, I. M., van Tintelen, J. P., Smeets, H. J. M., Meyer, H., & Geelen, J. L. M. C. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00578-6 · Cited by 311
Problems of Heart Rate Correction in Assessment of Drug‐Induced QT Interval Prolongation
MALIK, M. (2001) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2001.00411.x · Cited by 276
Bednar, M. M., Harrigan, E. P., Anziano, R. J., Camm, A. J., & Ruskin, J. N. (2001) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2001.21469 · Cited by 265
Hennessy, S., Bilker, W. B., Knauss, J. S., Margolis, D. J., Kimmel, S. E., Reynolds, R. F., Glasser, D. B., Morrison, M. F., & Strom, B. L. (2002) · BMJ · doi:10.1136/bmj.325.7372.1070 · Cited by 261
Contraindicated Use of Cisapride: Impact of Food and Drug Administration Regulatory Action
Smalley, W., Shatin, D., Wysowski, D. K., Gurwitz, J., Andrade, S. E., Goodman, M., Chan, K. A., Platt, R., Schech, S. D., & Ray, W. A. (2000) · JAMA · doi:10.1001/jama.284.23.3036 · Cited by 255
Tatro, D. S. (1990) · Cited by 254
Morganroth, J., Brozovich, F. V., McDonald, J. T., & Jacobs, R. A. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90541-r · Cited by 183
Clinical and therapeutic aspects of congenital and acquired long QT syndrome
Khan, I. A. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01011-7 · Cited by 179
Morganroth, J., & Goin, J. E. (1991) · Circulation · doi:10.1161/01.cir.84.5.1977 · Cited by 170
Anderson, M. E., Al‐Khatib, S. M., Roden, D. M., & Califf, R. M. (2002) · American Heart Journal · doi:10.1067/mhj.2002.125804 · Cited by 160
Self-citationPrescription of QT-prolonging drugs in a cohort of about 5 million outpatients
Curtis, L. H., Østbye, T., & Sendersky, V. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00200-9 · Cited by 148
Cooper, G. J., & Ryan, J. (1990) · British journal of surgery · doi:10.1002/bjs.1800770604 · Cited by 143
Mechanisms and management of proarrhythmia
Roden, D. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00472-x · Cited by 127
Risks and Benefits of Antiarrhythmic Therapy
Wood, A. J. J., & Roden, D. M. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311207 · Cited by 123
Maisel, W. H., Kuntz, K. M., Reimold, S. C., Lee, T. H., Antman, E. M., Friedman, P. L., & Stevenson, W. G. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-4-199708150-00004 · Cited by 122
QT Interval Prolongation in Acute Myocardial Infarction
Ahnve, S. (1985) · European Heart Journal · doi:10.1093/eurheartj/6.suppl_d.85 · Cited by 116
QT interval change with age in an overtly healthy older population
Reardon, M., & Malik, M. (1996) · Clinical Cardiology · doi:10.1002/clc.4960191209 · Cited by 114
Comparison of Formulae for Heart Rate Correction of QT Interval in Exercise Electrocardiograms
Aytemir, K., Maarouf, N., Gallagher, M. M., Yap, Y. G., Waktare, J. E. P., & Malík, M. (1999) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1999.tb00635.x · Cited by 92
Chung, M. K., Schweikert, R. A., Wilkoff, B. L., Niebauer, M. J., Pinski, S. L., Trohman, R. G., Kidwell, G. A., Jaeger, F. J., Morant, V. A., Miller, D. P., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00189-2 · Cited by 91
“Optimum” Formulae for Heart Rate Correction of the QT Interval
Hnatkova, K., & Malík, M. (1999) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1999.tb00390.x · Cited by 74
The Ventricular Paced QT Interval—The Effects of Rate and Exercise
Milne, J. R., Ward, D. E., Spurrell, R. A., & Camm, A. J. (1982) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1982.tb02242.x · Cited by 71
Hansten and Horn's drug interactions analysis and management
Hansten, P. D., & Horn, J. R. (2003) · Medical Entomology and Zoology · Cited by 48
Camm, A. J., Malík, M., & Yap, Y. G. (2004) · Medical Entomology and Zoology · Cited by 47
Hand Grenade Injuries Among Civilians
Coupland, R. M. (1993) · JAMA · doi:10.1001/jama.1993.03510050090034 · Cited by 37
Simons, G. R., Eisenstein, E. L., Shaw, L. J., Mark, D. B., & Pritchett, E. L. C. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00773-x · Cited by 35
Cited by
McClave, S. A., Taylor, B. E., Martindale, R. G., Warren, M. M., Johnson, D. R., Braunschweig, C., McCarthy, M. S., Davanos, E., Rice, T. W., Cresci, G. A., et al. (2016) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607115621863 · Cited by 3,982
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw211 · Cited by 2,544
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.654 · Cited by 1,795
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
Vogel, B., Acevedo, M., Appelman, Y., Bairey Merz, C. N., Chieffo, A., Figtree, G. A., Guerrero, M., Kunadian, V., Lam, C. S. P., Maas, A. H. E. M., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00684-x · Cited by 1,488
Taylor, B. E., McClave, S. A., Martindale, R. G., Warren, M. M., Johnson, D. R., Braunschweig, C., McCarthy, M. S., Davanos, E., Rice, T. W., Cresci, G. A., et al. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001525 · Cited by 1,476
“Both agents have been associated with QT prolongation, predisposing to cardiac arrhythmias (138, 139).”
Background
Metadata
- Authors
- Al-Khatib, S. M., LaPointe, N. M. A., Kramer, J. M., & Califf, R. M.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2003-04-23
- Volume
- 289
- Issue
- 16
- Pages
- 2120-7
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2163966221
- Cited by
- 667
- References
- 49
- FWCI
- 22.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.